Lupin launches Bromfenac Ophthalmic Solution, 0.075 per cent, Health News, ET HealthWorld

[ad_1]

Bromfenac Ophthalmic Solution, 0.075 per cent is the generic equivalent of BromSite Ophthalmic Solution, 0.075 per cent, of Sun Pharmaceutical Industries Limited. It is indicated for the treatment of postoperative inflammation and the prevention of ocular pain in patients undergoing cataract surgery.

Online Bureau

  • Updated On Feb 13, 2024 at 05:31 PM IST

Mumbai: Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075 per cent, after receiving approval from the United States Food and Drug Administration (US FDA).

Bromfenac Ophthalmic Solution, 0.075 per cent is the generic equivalent of BromSite Ophthalmic Solution, 0.075 per cent, of Sun Pharmaceutical Industries Limited. It is indicated for the treatment of postoperative inflammation and the prevention of ocular pain in patients undergoing cataract surgery.

Bromfenac Ophthalmic Solution 0.075 per cent (RLD BromSite) had estimated annual sales of $15 million in the US (IQVIA MAT December 2023).

  • Published On Feb 13, 2024 at 05:31 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *